The TECPR2 gene SPG49 genetic test is a specialized diagnostic procedure aimed at detecting mutations in the TECPR2 gene, which are associated with a rare neurodegenerative disorder known as spastic paraplegia 49 (SPG49). This condition is part of a group of genetic disorders known as hereditary spastic paraplegias (HSP), characterized by progressive stiffness and contraction (spasticity) in the lower limbs. SPG49, in particular, is distinguished by additional features that may include intellectual disability, developmental delays, and problems with the autonomic nervous system.
DNA Labs UAE offers this genetic test, providing a critical tool for the accurate diagnosis of SPG49. The test involves analyzing the patient's DNA to look for specific mutations in the TECPR2 gene that are indicative of the disorder. Early and precise diagnosis through this test can facilitate appropriate clinical management, counseling, and support for affected individuals and their families.
The cost of the TECPR2 gene SPG49 genetic test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test and the comprehensive analysis required to identify the genetic mutations associated with SPG49. Patients interested in undergoing this test are advised to consult with their healthcare provider to understand the implications of the results and to discuss the best course of action based on the outcome.
The AP4M1 Gene SPG50 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the AP4M1 gene, which are linked to Spastic Paraplegia 50 (SPG50). SPG50 is a rare neurodegenerative disorder characterized by progressive weakness and spasticity of the lower limbs, intellectual disability, and other neurological symptoms. Early and accurate diagnosis through genetic testing can be crucial for managing the condition, enabling tailored treatment plans, and providing valuable information for family planning.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities associated with SPG50. Given the complexity of the test and the sophisticated technology used, the cost of the AP4M1 Gene SPG50 Genetic Test at DNA Labs UAE is set at 4400 AED. This investment in health can provide individuals and families with essential insights into the genetic basis of symptoms observed, potentially leading to improved outcomes through early intervention and support.
The AP4E1 gene, associated with Spastic Paraplegia 51 (SPG51), plays a crucial role in the development and function of the nervous system. Mutations in this gene can lead to a range of neurological disorders, including SPG51, a form of hereditary spastic paraplegia. This condition is characterized by progressive weakness and spasticity of the legs, often accompanied by developmental delay, intellectual disability, and other neurological complications.
To diagnose this condition, the AP4E1 Gene SPG51 Genetic Test is conducted. This specialized genetic test is designed to detect mutations in the AP4E1 gene, providing crucial information for diagnosis, management, and genetic counseling of affected individuals and their families.
The test is available at DNA Labs UAE, a leading facility in genetic testing and personalized medicine. DNA Labs UAE employs state-of-the-art technology and adheres to international standards in genetic testing, ensuring accurate and reliable results.
The cost of the AP4E1 Gene SPG51 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to identify mutations in the AP4E1 gene, offering individuals and families critical insights into their genetic health and aiding in the management of SPG51.
The AP4S1 gene SPG52 genetic test is a specialized diagnostic procedure designed to detect mutations in the AP4S1 gene, which are linked to Spastic Paraplegia 52 (SPG52). SPG52 is a rare genetic disorder characterized by progressive weakness and stiffness of the legs, part of a group of disorders known as hereditary spastic paraplegias. These mutations can lead to various neurological symptoms, including developmental delay, intellectual disability, and problems with movement and coordination.
Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, this test is pivotal for early diagnosis and management of SPG52. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the AP4S1 gene. The results can provide valuable information for affected individuals and their families, including insights into the condition's progression, potential treatments, and the risk of passing the disorder to future generations.
The cost of the AP4S1 gene SPG52 genetic test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive analysis and expertise required to accurately identify mutations in the AP4S1 gene and provide a conclusive diagnosis. For families and individuals facing the possibility of SPG52, this test represents a crucial step towards understanding and managing the condition.
The VPS37A Gene SPG53 Genetic Test is a specialized diagnostic examination designed to identify mutations in the VPS37A gene, which are associated with Spastic Paraplegia 53 (SPG53), a rare form of hereditary spastic paraplegia. This condition typically manifests in early childhood and is characterized by progressive weakness and spasticity of the lower limbs, leading to mobility difficulties and other neurological symptoms.
The test is crucial for families with a history of SPG53, offering them an opportunity for early diagnosis, which is essential for managing symptoms, planning treatment strategies, and understanding the risk for future generations. It involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for any genetic alterations in the VPS37A gene.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test ensures accuracy and confidentiality. The cost of the VPS37A Gene SPG53 Genetic Test is set at 4400 AED, reflecting the sophisticated technology and expertise required to conduct this specialized analysis. For families affected by hereditary spastic paraplegia, this test represents a critical step towards personalized medicine and improved quality of life.
The DDHD2 Gene SPG54 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the DDHD2 gene, which are associated with Spastic Paraplegia 54 (SPG54). This condition is part of a group of genetic disorders known as hereditary spastic paraplegias (HSP), characterized by progressive weakness and spasticity of the legs. Early and accurate diagnosis through this test enables better management and understanding of the condition, offering insights into potential treatment and therapy options. The test cost is set at 4400 AED, reflecting the comprehensive analysis and detailed report provided by DNA Labs UAE, a leading facility in genetic diagnostics.
The C12ORF65 gene, associated with spastic paraplegia 55 (SPG55), is a critical focus in genetic testing for individuals experiencing symptoms of this inherited condition. Spastic paraplegia 55 is a form of hereditary spastic paraplegia, characterized by progressive weakness and stiffness of the legs. The C12ORF65 gene plays a significant role in mitochondrial function, and mutations in this gene can disrupt cellular energy production, leading to the symptoms observed in SPG55.
DNA Labs UAE offers a specialized genetic test targeting the C12ORF65 gene to diagnose SPG55. This test is essential for individuals presenting symptoms of spastic paraplegia, as it can confirm the diagnosis and help in the management of the condition. The test involves analyzing the patient's DNA to identify mutations in the C12ORF65 gene that are known to cause SPG55.
The cost of the C12ORF65 gene SPG55 genetic test at DNA Labs UAE is 4400 AED. This price includes the collection of a DNA sample, usually through a blood draw or cheek swab, and the comprehensive analysis of the C12ORF65 gene. Upon completion of the test, a detailed report is provided, outlining the findings and their implications for the patient's health and treatment options. This genetic test is a valuable tool for affected individuals and their families to understand their genetic makeup and to make informed decisions regarding their health care and management of the condition.
The CYP2U1 gene SPG56 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the CYP2U1 gene, which have been associated with a rare neurological disorder known as spastic paraplegia 56 (SPG56). This condition is part of a group of genetic disorders known as hereditary spastic paraplegias (HSPs), which are characterized by progressive stiffness and contraction (spasticity) in the lower limbs. The CYP2U1 gene plays a crucial role in the nervous system's development and function, and mutations in this gene can lead to the symptoms observed in SPG56.
The test is conducted at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any mutations in the CYP2U1 gene. This test is critical for individuals with a family history of HSPs or those exhibiting symptoms of SPG56, as it can provide a definitive diagnosis of the condition.
The cost of the CYP2U1 gene SPG56 genetic test at DNA Labs UAE is 4400 AED. This price includes the collection of the sample, laboratory analysis, and a comprehensive report detailing the test results. It's important for patients considering this test to consult with a healthcare provider or genetic counselor to understand the implications of the results and to discuss potential treatment options and management strategies for SPG56.
The TFG Gene SPG57 Genetic Test is a specialized diagnostic tool used to identify mutations in the TFG gene, which are associated with SPG57, a form of hereditary spastic paraplegia. This condition is characterized by progressive stiffness and weakness of the legs, resulting from the degeneration of nerve pathways responsible for transmitting signals from the brain to the spinal cord and then to the muscles.
DNA Labs UAE offers this genetic test to help in the diagnosis and management of SPG57. By analyzing a sample of the patient's DNA, the test can detect specific genetic alterations in the TFG gene that are linked to the condition, providing crucial information for accurate diagnosis, treatment planning, and genetic counseling.
The cost of the TFG Gene SPG57 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the sophisticated laboratory procedures and expert analysis required to identify the presence of the genetic mutation associated with SPG57. For patients and families affected by hereditary spastic paraplegia, this test represents a critical step towards understanding their condition and making informed health care decisions.
The USP8 Gene SPG59 USP8 Related Genetic Test is a specialized diagnostic procedure designed to identify mutations in the USP8 gene, which are linked to Spastic Paraplegia 59 (SPG59). SPG59 is a rare genetic disorder characterized by progressive weakness and spasticity of the legs. This condition is part of a group of disorders known as hereditary spastic paraplegias, which affect the nerve pathways from the brain to the muscles.
The test specifically targets the USP8 gene to detect any genetic anomalies that may be responsible for the symptoms associated with SPG59. By analyzing the genetic material, healthcare providers can gain crucial insights into the condition, enabling them to make more informed decisions regarding the patient's management and treatment plans.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the USP8 Gene SPG59 USP8 Related Genetic Test is performed with the highest standards of accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and detailed reporting provided.
For patients exhibiting symptoms of SPG59 or those with a family history of hereditary spastic paraplegias, this test offers a valuable diagnostic tool. Early detection through genetic testing can significantly impact the management of the condition, potentially improving the quality of life for those affected.
